Kaye WH - Search Results

1

Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa.

Bailer UF, Frank GK, Price JC, Meltzer CC, Becker C, Mathis CA, Wagner A, Barbarich-Marsteller NC, Bloss CS, Putnam K, Schork NJ, Gamst A, Kaye WH. Bailer UF, et al. Among authors: kaye wh. Psychiatry Res. 2013 Feb 28;211(2):160-8. doi: 10.1016/j.pscychresns.2012.06.010. Epub 2012 Nov 13. Psychiatry Res. 2013. PMID: 23154100 Free PMC article.

2

Drug use in women with bulimia and anorexia nervosa.

Bulik CM, Epstein LH, McKee M, Kaye W. Bulik CM, et al. NIDA Res Monogr. 1990;105:462-3. NIDA Res Monogr. 1990. PMID: 1876079 No abstract available.

3

Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.

Kaye W, Gendall K, Strober M. Kaye W, et al. Biol Psychiatry. 1998 Nov 1;44(9):825-38. doi: 10.1016/s0006-3223(98)00195-4. Biol Psychiatry. 1998. PMID: 9807638 Review.

4

Controlled family study of anorexia nervosa and bulimia nervosa: evidence of shared liability and transmission of partial syndromes.

Strober M, Freeman R, Lampert C, Diamond J, Kaye W. Strober M, et al. Am J Psychiatry. 2000 Mar;157(3):393-401. doi: 10.1176/appi.ajp.157.3.393. Am J Psychiatry. 2000. PMID: 10698815

5

Reduced 5-HT2A receptor binding after recovery from anorexia nervosa.

Frank GK, Kaye WH, Meltzer CC, Price JC, Greer P, McConaha C, Skovira K. Frank GK, et al. Among authors: kaye wh. Biol Psychiatry. 2002 Nov 1;52(9):896-906. doi: 10.1016/s0006-3223(02)01378-1. Biol Psychiatry. 2002. PMID: 12399143

6

Olanzapine treatment of anorexia nervosa: a retrospective study.

Malina A, Gaskill J, McConaha C, Frank GK, LaVia M, Scholar L, Kaye WH. Malina A, et al. Among authors: kaye wh. Int J Eat Disord. 2003 Mar;33(2):234-7. doi: 10.1002/eat.10122. Int J Eat Disord. 2003. PMID: 12616591 Clinical Trial.

7

Anxiolytic effects of acute tryptophan depletion in anorexia nervosa.

Kaye WH, Barbarich NC, Putnam K, Gendall KA, Fernstrom J, Fernstrom M, McConaha CW, Kishore A. Kaye WH, et al. Int J Eat Disord. 2003 Apr;33(3):257-67; discussion 268-70. doi: 10.1002/eat.10135. Int J Eat Disord. 2003. PMID: 12655621 Clinical Trial.

8

A review of neuropeptide and neuroendocrine dysregulation in anorexia and bulimia nervosa.

Bailer UF, Kaye WH. Bailer UF, et al. Among authors: kaye wh. Curr Drug Targets CNS Neurol Disord. 2003 Feb;2(1):53-9. doi: 10.2174/1568007033338689. Curr Drug Targets CNS Neurol Disord. 2003. PMID: 12769812 Review.

9

Pain perception in recovered bulimia nervosa patients.

Stein D, Kaye WH, Matsunaga H, Myers D, Orbach I, Har-Even D, Frank G, Rao R. Stein D, et al. Among authors: kaye wh. Int J Eat Disord. 2003 Nov;34(3):331-6. doi: 10.1002/eat.10164. Int J Eat Disord. 2003. PMID: 12949924

10

Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa.

Barbarich NC, McConaha CW, Halmi KA, Gendall K, Sunday SR, Gaskill J, La Via M, Frank GK, Brooks S, Plotnicov KH, Kaye WH. Barbarich NC, et al. Among authors: kaye wh. Int J Eat Disord. 2004 Jan;35(1):10-5. doi: 10.1002/eat.10235. Int J Eat Disord. 2004. PMID: 14705152 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters